| Title | MS200095_0022 CSR FDA submission gene result data (SDTM datasets) |
|---|---|
| Description | For MS200095_0022 study, by 20Nov2022, all subjects has been treated for at least 18 moths, and as per FDA request, Merck needs to submit all subjects 18 months follow up data for efficacy confirmation, because all summarized data just includes MET ex14 gene result data: positive or negative, does not include MET ex14 raw data, So as per HGR request, the study team will do OMIX database upload. |
| Organism | Homo sapiens |
| Data Type | Other Type of Genomic Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA011896 |
| Release Date | 2026-01-30 |
| Submitter | Huiru Yuwen (jessie.yuwen@merckgroup.com) |
| Organization | Guangdong Provincial People's Hospital |
| Submission Date | 2022-12-30 |
The data cannot be downloaded as it has not yet been registered in the Human Genetic Resource Management Platform of MOST.
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download |
|---|---|---|---|---|---|---|
| OMIX002703-01 | MS200095_0022 CSR FDA submission gene result data (SDTM datasets) | 1 | Other Type of Genomic Data | 263.6 KB | zip | Unavailable |
| Paper Title | Journal Name | Publish Time | Accession | Citing Type |
|---|